These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 1911705

  • 1. Effect of aspirin and epinephrine on experimentally induced thrombogenesis in dogs. A parallelism between in vivo and ex vivo thrombosis models.
    Roux SP, Sakariassen KS, Turitto VT, Baumgartner HR.
    Arterioscler Thromb; 1991; 11(5):1182-91. PubMed ID: 1911705
    [Abstract] [Full Text] [Related]

  • 2. Sodium nitroprusside, an endothelium-derived relaxing factor congener, increases platelet cyclic GMP levels and inhibits epinephrine-exacerbated in vivo platelet thrombus formation in stenosed canine coronary arteries.
    Rovin JD, Stamler JS, Loscalzo J, Folts JD.
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):626-31. PubMed ID: 7505366
    [Abstract] [Full Text] [Related]

  • 3. High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets.
    Bertha BG, Sill JC, Berger I, Folts JD, Milde JH.
    Anesthesiology; 1993 Apr; 78(4):733-43. PubMed ID: 8466073
    [Abstract] [Full Text] [Related]

  • 4. Effects of trimetazidine on in vivo coronary arterial platelet thrombosis.
    Belcher PR, Drake-Holland AJ, Hynd JW, Noble MI.
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):149-57. PubMed ID: 8485070
    [Abstract] [Full Text] [Related]

  • 5. Epinephrine potentiation of in vivo stimuli reverses aspirin inhibition of platelet thrombus formation in stenosed canine coronary arteries.
    Folts JD, Rowe GG.
    Thromb Res; 1988 May 15; 50(4):507-16. PubMed ID: 3413717
    [Abstract] [Full Text] [Related]

  • 6. DTTX30, a combined thromboxane receptor antagonist and thromboxane synthetase inhibitor, prevents coronary thrombosis in anesthetized dogs.
    Guth BD, Müller TH.
    Basic Res Cardiol; 1997 Jun 15; 92(3):181-90. PubMed ID: 9226103
    [Abstract] [Full Text] [Related]

  • 7. High dose intravenous aspirin, not low dose intravenous or oral aspirin, inhibits thrombus formation and stabilizes blood flow in experimental coronary vascular injury.
    Mickelson JK, Hoff PT, Homeister JW, Fantone JC, Lucchesi BR.
    J Am Coll Cardiol; 1993 Feb 15; 21(2):502-10. PubMed ID: 8426017
    [Abstract] [Full Text] [Related]

  • 8. Aurintricarboxylic acid in a canine model of coronary artery thrombosis.
    Strony J, Phillips M, Brands D, Moake J, Adelman B.
    Circulation; 1990 Mar 15; 81(3):1106-14. PubMed ID: 2306818
    [Abstract] [Full Text] [Related]

  • 9. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR, Lynch JJ, Sitko GR, Mellott MJ, Holahan MA, Stabilito II, Stranieri MT, Zhang G, Lynch RJ, Manno PD.
    J Pharmacol Exp Ther; 1993 Sep 15; 266(3):1501-11. PubMed ID: 8371153
    [Abstract] [Full Text] [Related]

  • 10. Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis.
    Makkar RR, Litvack F, Eigler NL, Nakamura M, Ivey PA, Forrester JS, Shah PK, Jordan RE, Kaul S.
    Circulation; 1997 Feb 18; 95(4):1015-21. PubMed ID: 9054765
    [Abstract] [Full Text] [Related]

  • 11. Dynamic intracoronary thrombosis does not cause significant downstream platelet embolization.
    Barrabés JA, Garcia-Dorado D, Soriano B, Solares J, Puigfel Y, Trobo L, Garcia-Lafuente A, Soler-Soler J.
    Cardiovasc Res; 2000 Aug 18; 47(2):265-73. PubMed ID: 10946063
    [Abstract] [Full Text] [Related]

  • 12. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
    Golino P, Ambrosio G, Ragni M, Pascucci I, Triggiani M, Oriente A, McNatt J, Buja LM, Condorelli M, Chiariello M.
    Circulation; 1993 Sep 18; 88(3):1205-14. PubMed ID: 8353882
    [Abstract] [Full Text] [Related]

  • 13. Interaction between plasma potassium and epinephrine in coronary thrombosis in dogs.
    Lin H, Young DB.
    Circulation; 1994 Jan 18; 89(1):331-8. PubMed ID: 8281666
    [Abstract] [Full Text] [Related]

  • 14. Opposing effects of plasma epinephrine and norepinephrine on coronary thrombosis in vivo.
    Lin H, Young DB.
    Circulation; 1995 Feb 15; 91(4):1135-42. PubMed ID: 7850952
    [Abstract] [Full Text] [Related]

  • 15. Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets.
    Mailhac A, Badimon JJ, Fallon JT, Fernández-Ortiz A, Meyer B, Chesebro JH, Fuster V, Badimon L.
    Circulation; 1994 Aug 15; 90(2):988-96. PubMed ID: 8044972
    [Abstract] [Full Text] [Related]

  • 16. Sildenafil improves coronary artery patency in a canine model of platelet-mediated cyclic coronary occlusion after thrombolysis.
    Lewis GD, Witzke C, Colon-Hernandez P, Guerrero JL, Bloch KD, Semigran MJ.
    J Am Coll Cardiol; 2006 Apr 04; 47(7):1471-7. PubMed ID: 16580539
    [Abstract] [Full Text] [Related]

  • 17. Effects of MDL 28,133A, a 5-HT2 receptor antagonist, on platelet aggregation and coronary thrombosis in dogs.
    Hsieh CP, Sakai K, Bruns GC, Dage RC.
    J Cardiovasc Pharmacol; 1994 Nov 04; 24(5):761-72. PubMed ID: 7532754
    [Abstract] [Full Text] [Related]

  • 18. Thrombin inhibition and intracoronary thrombus formation: effect of polyethylene glycol-coupled hirudin in the stenosed, locally injured canine coronary artery.
    Rübsamen K, Kirchengast M.
    Coron Artery Dis; 1998 Nov 04; 9(1):35-42. PubMed ID: 9589189
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of platelet activity in vivo by amlodipine alone and combined with aspirin.
    Folts JD.
    Int J Cardiol; 1997 Dec 31; 62 Suppl 2():S111-7. PubMed ID: 9488202
    [Abstract] [Full Text] [Related]

  • 20. Inhibition by the combined Ca2+ and 5-HT2 receptor antagonist nexopamil (LU 49938) of intracoronary thrombus formation in a canine model of arterial stenosis and intimal damage.
    Kirchengast M, Rübsamen K, Lehmann HD.
    J Cardiovasc Pharmacol; 1993 Nov 31; 22(5):687-94. PubMed ID: 7506319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.